Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation

Min Soo Ahn, Byung Su Yoo, Junghan Yoon, Seung Hwan Lee, Jang Young Kim, Sung Gyun Ahn, Young Jin Youn, Jun Won Lee, Jung Woo Son, Hye Sim Kim, Dae Ryong Kang, Hyun Jai Cho, Hae Young Lee, Eun Seok Jeon, Seok Min Kang, Dong Ju Choi, Myeong Chan Cho

Research output: Contribution to journalArticlepeer-review

4 Citations (Scopus)


Objectives This study evaluated the relationship between guideline adherence for recommended therapy on discharge and relevant 60-day and 1-year clinical outcomes in patients with acute heart failure (HF) with reduced ejection fraction and atrial fibrillation (AF). Methods Of 5625 acute patients with HF in the Korean Acute Heart Failure registry, 986 patients with HF and documented AF were analysed. Guideline adherence scores were calculated for the prescription of ACE inhibitors, angiotensin receptor blockers, β-blockers, mineralocorticoid receptor antagonists and anticoagulants. Results In patients with HF with AF, there was a significant trend of reduced 60-day and 1-year mortality rates and the composite end point with guideline adherence. According to the Cox proportion hazard model, poor adherence was associated with a significantly higher risk of 60-day mortality (HR 4.75; 95% CI 1.77 to 12.74) and the composite end point (HR 2.36; 95% CI 1.33 to 4.18) compared with good adherence. Furthermore, poor adherence was associated with a significantly higher risk of 1-year mortality compared with moderate (HR 1.64; 95% CI 1.15 to 2.33) and good adherence (HR 2.34; 95% CI 1.39 to 3.97) and with a higher risk of the 1-year composite end point compared with good adherence (HR 1.58; 95% CI 1.07 to 2.33). Conclusion Better adherence to guidelines was associated with better 60-day and 1-year prognoses in patients with HF with AF.

Original languageEnglish
Pages (from-to)292-298
Number of pages7
Issue number4
Publication statusPublished - 2020 Feb 1

Bibliographical note

Funding Information:
Funding This work was supported by research of Korea centers for Disease control and Prevention (grant nos. 2010-e63003-00,2011-e63002-00, 2012-e63005-00, 2013-e63003-00, 2013-e63003-01, 2013-e63003-02 and 2016-er6303-00).

Publisher Copyright:
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation'. Together they form a unique fingerprint.

Cite this